Effect of Xen Implantation on the Aqueous Humor Proteome

NCT04141865 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 3

Last updated 2022-03-03

No results posted yet for this study

Summary

The purpose of this study is to determine how the aqueous humor proteome changes after implantation of a Xen microstent for treatment of glaucoma.

Conditions

  • Primary Open Angle Glaucoma

Interventions

DEVICE

Xen

Xen microstent implantation

DEVICE

Aqueous shunt

Aqueous shunt implantation

Sponsors & Collaborators

  • Price Vision Group

    lead INDUSTRY

Principal Investigators

  • Francis Price, Jr, MD · Price Vision Group

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-24
Primary Completion
2022-02-15
Completion
2022-02-15
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04141865 on ClinicalTrials.gov